PROTEOSTASIS THERAPEUTICS, INC. (53) | Business Finance (19)

Browse by Subcategory

Recent Contracts

Sixth Amendment and Consent to Loan and Security Agreement dated as of April 13, 2021, by and among Yumanity, Inc., the lenders party thereto and Hercules Capital, Inc (Filed With SEC on August 12, 2021)
Amended and Restated Warrant Agreement to Purchase Common Stock of the Company issued to Hercules Capital, Inc., dated December 22, 2020 (Filed With SEC on March 31, 2021)
Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan and forms of award agreements thereunder (Filed With SEC on December 30, 2020)
Registration Rights Agreement, dated as of December 22, 2020 by among the Company (formerly known as Proteostasis Therapeutics, Inc.) and certain purchasers listed therein (Filed With SEC on December 30, 2020)
Unconditional Secured Guaranty and Pledge Agreement, dated December 22, 2020 by and between the Company (formerly known as Proteostasis Therapeutics, Inc.) and Hercules Capital,... (Filed With SEC on December 30, 2020)
Subscription Agreement, dated as of December 14, 2020 by and among Proteostasis Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on December 15, 2020)
U.S. Small Business Administration Paycheck Protection Program Note with Silicon Valley Bank, dated as of April 24, 2020 (Filed With SEC on September 23, 2020)
Assignment and Release Agreement between the Company and Cystic Fibrosis Foundation, dated December 19, 2018 (Filed With SEC on March 8, 2019)
Fifth Amendment and Consent to Loan and Security Agreement dated as of March 29, 2021, by and among Yumanity, Inc., the lenders party thereto and Hercules Capital, Inc (Filed With SEC on May 13, 2021)
Fourth Amendment and Consent to Loan and Security Agreement dated as of December 22, 2020, by and among Yumanity, Inc. (formerly Yumanity Therapeutics, Inc.), the lenders party... (Filed With SEC on December 30, 2020)
Form of Registration Rights Agreement (Filed With SEC on December 15, 2020)
Warrant to Purchase Limited Liability Company Interests issued to Oxford Finance LLC dated June 14, 2018 (Filed With SEC on September 23, 2020)
Loan and Security Agreement, by and among Yumanity Therapeutics, Inc. and Hercules Capital, Inc., dated as December 20, 2019 (Filed With SEC on September 23, 2020)
Warrant to Purchase Limited Liability Company Interests issued to Silicon Valley Bank on June 14, 2018 (Filed With SEC on September 23, 2020)
Common Unit Warrant issued to N. Anthony Coles on August 14, 2015 (Filed With SEC on September 23, 2020)
Common Unit Warrant issued to Redmile Biotechnologies Investments I AF, LP (as predecessor to Redmile Biopharma Investments I, L.P.) on August 14, 2015 (Filed With SEC on September 23, 2020)
Common Unit Warrant issued to Redmile Capital Offshore II Master Fund, Ltd. on August 14, 2015 (Filed With SEC on September 23, 2020)
Common Unit Warrant issued to Alexandria Equities, LLC (as predecessor to Alexandria Venture Investments, LLC) on October 9, 2015 (Filed With SEC on September 23, 2020)
Warrant Agreement to Purchase Preferred Units of Yumanity Holdings, LLC issued to Hercules Capital, Inc., dated December 20, 2019 (Filed With SEC on September 23, 2020)